Jonathan E. McDermed

Intermittent Androgen Deprivation in Prostate Cancer Patients: Factors Predictive of Prolonged Time Off Therapy

Stephen B. Strum, Mark C. Scholz, Jonathan E. McDermed · The Oncologist · 2000 · 67 citations · Full text

Medicine, Endocrinology, Oncology +17

Intravenous metoclopramide: Prevention of chemotherapy-induced nausea and vomiting. A preliminary evaluation

Stephen B. Strum, Jonathan E. McDermed, Joanne Pileggi et al. · Cancer · 1984 · 51 citations

Medicine, Pharmacology, Pharmacotherapy +16

Nucleic Acid Detection Immunoassay for Prostate-Specific Antigen Based on Immuno-PCR Methodology

Jonathan E. McDermed, Ron Sanders, Stephen Fait et al. · Clinical Chemistry · 2012 · 30 citations

Medicine, Molecular Biology, Oncology +15

NADiA ProsVue Prostate-specific Antigen Slope Is an Independent Prognostic Marker for Identifying Men at Reduced Risk of Clinical Recurrence of Prostate Cancer After Radical Prostatectomy

Judd W. Moul, Hans Lilja, O. John Semmes et al. · Urology · 2012 · 13 citations

Medicine, Oncology, Urology +17

Clinical Pharmacokinetics of High-Dose Metoclopramide in Cancer Patients Receiving Cisplatin Therapy

Jonathan E. McDermed, J. Louis Cohen, Corrine Joseph et al. · Journal of Clinical Oncology · 1985 · 13 citations

Medicine, Clinical Pharmacokinetics, Pharmacology +11